Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation

Technology appraisal guidance
Reference number: TA256
Published: 23 May 2012
Last updated: 02 July 2021

Atrial fibrillation (stroke prevention) - rivaroxaban: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)

Atrial fibrillation (stroke prevention) - rivaroxaban: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)

Atrial fibrillation (stroke prevention) - rivaroxaban: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)
30 March 2012
(610.47 Kb 57 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 29 March 2012